Brannan Stephen K.

Chief Medical OfficerKaruna Therapeutics, Inc. (KRTX) · full profile →Form 4 · filed Mar 11, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.6M
Net Open-Market Flow
-$1.6M
Transactions
8
5 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 8, 2024Option exercise(M)3K$5.45$14K43K
Mar 8, 2024Option exercise(M)3K$131.64$422K46K
Mar 8, 2024Option exercise(M)2K$111.97$201K48K
Mar 8, 2024Sell(S)5K$318.33$1.6M43K
Mar 8, 2024Sell(S)100$318.96$32K43K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 8, 2024Option exercise(M)3K$05K
Mar 8, 2024Option exercise(M)3K$013K
Mar 8, 2024Option exercise(M)2K$038K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-029406) within minutes of acceptance. Every field above traces to the original document. Verify it directly: